A detailed history of Raymond James Financial Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Raymond James Financial Inc holds 10,137,651 shares of JNJ stock, worth $2.02 Billion. This represents 0.63% of its overall portfolio holdings.

Number of Shares
10,137,651
Previous 9,446,764 7.31%
Holding current value
$2.02 Billion
Previous $1.44 Billion 30.27%
% of portfolio
0.63%
Previous 0.51%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$155.17 - $185.42 $107 Million - $128 Million
690,887 Added 7.31%
10,137,651 $1.88 Billion
Q2 2025

Aug 14, 2025

SELL
$146.36 - $159.82 $3.12 Million - $3.41 Million
-21,350 Reduced 0.23%
9,446,764 $1.44 Billion
Q1 2025

May 13, 2025

BUY
$142.06 - $167.7 $28.9 Million - $34.1 Million
203,291 Added 2.19%
9,468,114 $1.57 Billion
Q4 2024

Feb 06, 2025

BUY
$143.34 - $165.86 $1.33 Billion - $1.54 Billion
9,264,823 New
9,264,823 $1.34 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Raymond James Financial Inc Portfolio

Follow Raymond James Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Inc with notifications on news.